User expertshadow7

Member for: 4 months (since Aug 13)
Type: Registered user
First Name:
Last Name:
Location:
Website: https://www.selleckchem.com/products/jph203.html
About: Cycle 2 research involving ceralasertib (AZD6738) in combination with durvalumab inside patients with advanced/metastatic most cancers who have unsuccessful previous anti-PD1 therapy.
Company:
Skills:
Facebook Profile Link:
Twitter Profile Link:

Activity by expertshadow7

Score: 10 points (ranked #91)
topics: 0
replies: 0
Comments: 0
Voted on: 0 topics, 0 replies
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes
...